Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are pleased to welcome Professor Gerton Lunter and his research group, who will be joining the MRC WIMM Centre for Computational Biology.

The Lunter group is particularly interested in understanding the regulatory genome by building machine learning models that predict intermediate phenotypes from DNA sequence.  They use these models to predict whether mutations disrupt regulatory machinery or create cryptic functional sites, and try to understand how these models predict phenotype to possibly discover new biology.

Originally from the Netherlands, Prof Lunter did his PhD in mathematics at the University of Groningen. He has since worked in several departments at the University of Oxford, including the Department of Statistics, Department of Physiology, Anatomy and Genetics and the Wellcome Centre for Human Genetics, where he established his group in 2009. Talking about his move to the MRC WIMM Centre for Computational Biology, Prof Lunter said, "I'm excited to join the MRC WIMM, which is host to an exciting combination of world-class and focused research in computational and molecular biology, and I look forward to setting up collaborations to better understand the great puzzle of our time, the regulatory genome".

Prof Lunter is joined in our institute by his group members Richard Brown, Dan Cooke and Chris Cole.  With Jim Hughes he co-supervises Ron Schwessinger and Ravza Gür who are already based at the MRC WIMM.

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.